Germany · Delayed Price · Currency is EUR Tiziana Life Sciences Statistics
Total Valuation
FRA:0RP has a market cap or net worth of EUR 184.45 million. The enterprise value is 178.29 million.
| Market Cap | 184.45M |
| Enterprise Value | 178.29M |
Important Dates
The next estimated earnings date is Friday, December 26, 2025.
| Earnings Date | Dec 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 118.82M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.35% |
| Shares Change (QoQ) | +5.97% |
| Owned by Insiders (%) | 47.34% |
| Owned by Institutions (%) | 3.38% |
| Float | 62.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 23.55 |
| P/TBV Ratio | 23.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.31 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -23.90 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.72 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -232.31% and return on invested capital (ROIC) is -203.61%.
| Return on Equity (ROE) | -232.31% |
| Return on Assets (ROA) | -83.78% |
| Return on Invested Capital (ROIC) | -203.61% |
| Return on Capital Employed (ROCE) | -200.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.21M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +79.07% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +79.07% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 46.33 |
| Average Volume (20 Days) | 10 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.73M |
| Pretax Income | -12.26M |
| Net Income | -10.93M |
| EBITDA | -15.72M |
| EBIT | -15.73M |
| Earnings Per Share (EPS) | -0.10 |
Balance Sheet
The company has 6.17 million in cash and 91,111 in debt, giving a net cash position of 6.08 million.
| Cash & Cash Equivalents | 6.17M |
| Total Debt | 91,111 |
| Net Cash | 6.08M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.83M |
| Book Value Per Share | 0.07 |
| Working Capital | 4.53M |
Cash Flow
In the last 12 months, operating cash flow was -7.45 million and capital expenditures -9,367, giving a free cash flow of -7.46 million.
| Operating Cash Flow | -7.45M |
| Capital Expenditures | -9,367 |
| Free Cash Flow | -7.46M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:0RP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.35% |
| Shareholder Yield | -10.35% |
| Earnings Yield | -5.93% |
| FCF Yield | -4.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |